Would the Per Se Illegal Treatment of Reverse Payment Settlements Inhibit Generic Drug Investment?

Journal of Competition Law and Economics - United Kingdom
doi 10.1093/joclec/nhs021
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Oxford University Press (OUP)


Related search